EUVIMEDEUVIMED entdecken
Crossref

Prognostic Value of MRI Assessment of Residual Peritumoral Edema in Breast Cancer Treated With Neoadjuvant Chemotherapy

Hideo Shigematsu iD, Mutsumi Fujimoto, Yoshie Kobayashi, Daisuke Yasui, Daisuke Komoto, Noriaki Matsuura, Kazuya Kuraoka, Tomoyuki Yoshiyama

Journal of Magnetic Resonance Imaging · 2025

DOI: 10.1002/jmri.29456 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Magnetic Resonance Imaging, 2025. Verfasst von Hideo Shigematsu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery, National Hospital Organization Kure Medical Center and Chugoku Cancer Center, Hiroshima, Japan. Hauptthemen laut MEDLINE: Breast Neoplasms, Magnetic Resonance Imaging, Neoadjuvant Therapy, Edema. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: JSPS KAKENHI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Peritumoral edema (PE) identified on T2‐weighted breast MRI is a factor for poor prognosis in breast cancer.

Purpose

To assess the prognostic value of residual PE (rPE) in patients with PE positive breast cancer prior to neoadjuvant chemotherapy (NACT) who subsequently underwent curative surgery. Study Type Retrospective. Population In total, 128 patients with nonmetastatic invasive breast cancer who underwent breast MRI before and after NACT. Field Strength/Sequence Axial precontrast 2D fast spin echo T2W fat‐suppressed sequence. Axial dynamic 3D gradient echo T1W fat‐suppressed sequence. Assessment PE was diagnosed when a signal intensity as high as water was detected surrounding the tumor on a T2‐weighted breast MRI. PE was qualitatively evaluated by three readers with more than 20 years of experience in interpreting breast field imaging findings. Residual cancer burden (RCB) were assessed post‐NACT. Recurrence‐free survival (RFS) and overall survival (OS) were evaluated as the endpoints of this study. Statistical Tests Chi‐square test; Kaplan–Meier method, log‐rank test, and Cox proportional hazard model. A P ‐value

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsMagnetic Resonance ImagingNeoadjuvant TherapyEdemaHumansFemaleMiddle AgedRetrospective StudiesPrognosisAdultAgedBreastChemotherapy, Adjuvant

Stichwörter der Autor:innen

breast neoplasmsneoadjuvant chemotherapyoverall survivalperitumoral edemarelapse‐free survival

Autor:innen und Institutionen

  • Department of Breast Surgery, National Hospital Organization Kure Medical Center and Chugoku Cancer Center, Hiroshima, Japan.
  • Department of Radiology, National Hospital Organization Kure Medical Center and Chugoku Cancer Center, Hiroshima, Japan.
  • Department of Pathology, National Hospital Organization Kure Medical Center and Chugoku Cancer Center, Hiroshima, Japan.

ORCID-Profile: Hideo Shigematsu

Förderung

  • JSPS KAKENHI

Zitieren

APA

Shigematsu, H., Fujimoto, M., Kobayashi, Y., Yasui, D., Komoto, D., Matsuura, N., Kuraoka, K., & Yoshiyama, T. (2025). Prognostic Value of MRI Assessment of Residual Peritumoral Edema in Breast Cancer Treated With Neoadjuvant Chemotherapy. Journal of Magnetic Resonance Imaging. https://doi.org/10.1002/jmri.29456

Vancouver

Shigematsu H, Fujimoto M, Kobayashi Y, Yasui D, Komoto D, Matsuura N, et al. Prognostic Value of MRI Assessment of Residual Peritumoral Edema in Breast Cancer Treated With Neoadjuvant Chemotherapy. Journal of Magnetic Resonance Imaging. 2025. doi:10.1002/jmri.29456

BibTeX
@article{Shigematsu2025,
  author = {Shigematsu, Hideo and Fujimoto, Mutsumi and Kobayashi, Yoshie and Yasui, Daisuke and Komoto, Daisuke and Matsuura, Noriaki and Kuraoka, Kazuya and Yoshiyama, Tomoyuki},
  title = {Prognostic Value of MRI Assessment of Residual Peritumoral Edema in Breast Cancer Treated With Neoadjuvant Chemotherapy},
  journal = {Journal of Magnetic Resonance Imaging},
  year = {2025},
  doi = {10.1002/jmri.29456}
}
Kostenlos starten →